Modafinil for the Treatment of Cocaine Dependence - 1

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Cocaine-Related Disorders

Treatments: Drug: Modafinil

Study type: Interventional

Funder types: NIH

Identifiers

NCT00100100

NIDA-MDS-0004-1

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.

Full description

This is a double-blind, placebo-controlled, parallel group design study to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participant must have DSM-IV diagnosis of cocaine dependence as determined by SCID.
• Must be seeking treatment for cocaine dependence.
• Must be able to understand and provide written informed consent.

Exclusion criteria

• Please contact the study site for more information.